High-dose sequential followed by autologous hematopoietic stem cell transplantation for Hodgkin's disease (hd): a Brazilian experience

被引：0
|
作者：
Duarte, B. [1 ]
Valente, I. [1 ]
Vigorito, A. [1 ]
Aranha, F. [1 ]
Oliveira, G. [1 ]
Miranda, E. [1 ]
Lorand-Metze, I. [1 ]
Pagnano, K. [1 ]
De Souza, C. [1 ]
机构：
[1] Univ Estadual Campinas, Campinas, SP, Brazil
来源：
BONE MARROW TRANSPLANTATION | 2008年 / 41卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S246 / S246
页数：1
相关论文
共 50 条
  • [21] Efficacy and toxicity of CCNU-based high dose chemotherapy followed by autologous hematopoietic cell transplantation (HCT) in relapsed or refractory Hodgkin's disease (HD).
    Jain, M
    Chao, NJ
    Horning, SJ
    Negrin, RS
    Hu, WW
    Johnston, LJ
    Shizuru, JA
    Long, GD
    Blume, KG
    Stockerl-Goldstein, KE
    BLOOD, 1999, 94 (10) : 169A - 169A
  • [22] Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease
    Stuart, MJ
    Chao, NS
    Horning, SJ
    Wong, RM
    Negrin, RS
    Johnston, LJ
    Shizuru, JA
    Long, GD
    Blume, KG
    Stockerl-Goldstein, KE
    Goldstein, S
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2001, 7 (10) : 552 - 560
  • [23] BEAM or BuCyE high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients
    Kim, J.
    Kim, E.
    Sohn, B.
    Yoon, D.
    Yoo, C.
    Kim, S.
    Lee, D.
    Kim, S.
    Lee, J.
    Suh, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [24] BEAM OR BUCYE HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION IN NON-HODGKIN'S LYMPHOMA PATIENTS
    Suh, C.
    Kim, J. E.
    Sohn, B. S.
    Yoon, D. H.
    Lee, D. H.
    Kim, S. W.
    Lee, J. S.
    Kim, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 643 - 643
  • [25] Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma
    U Popat
    C Hosing
    R M Saliba
    P Anderlini
    K van Besien
    D Przepiorka
    I F Khouri
    J Gajewski
    D Claxton
    S Giralt
    M Rodriguez
    J Romaguera
    F Hagemeister
    C Ha
    J Cox
    F Cabanillas
    B S Andersson
    R E Champlin
    Bone Marrow Transplantation, 2004, 33 : 1015 - 1023
  • [26] High-dose therapy followed by stem cell transplantation in Hodgkin's lymphoma: past and future
    Isidori, Alessandro
    Piccaluga, Pier Paolo
    Loscocco, Federica
    Guiducci, Barbara
    Barulli, Sara
    Ricciardi, Teresa
    Picardi, Paola
    Visani, Giuseppe
    EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (04) : 451 - 464
  • [27] High-dose therapy and autologous hematopoietic stem-cell transplantation for recurrent or refractory pediatric Hodgkin's disease: Results and prognostic indices
    Lieskovsky, YE
    Donaldson, SS
    Torres, MA
    Wong, RM
    Amylon, MD
    Link, MP
    Agarwal, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (22) : 4532 - 4540
  • [28] Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma
    Popat, U
    Hosing, C
    Saliba, RM
    Anderlini, P
    van Besien, K
    Przepiorka, D
    Khouri, IF
    Gajewski, J
    Claxton, D
    Giralt, S
    Rodriguez, M
    Romaguera, J
    Hagemeister, F
    Ha, C
    Cox, J
    Cabanillas, F
    Andersson, BS
    Champlin, R
    BONE MARROW TRANSPLANTATION, 2004, 33 (10) : 1015 - 1023
  • [29] MAMI salvage therapy and high-dose chemotherapy (HDCT) followed by autologous hematopoietic stem cell transplantation in refractory or relapsing non Hodgkin's lymphoma (NHL).
    Bendahmane, B
    Bourhis, JH
    Munck, JN
    Koscielny, S
    Decaudin, D
    Brault, P
    Castagna, L
    Bosq, J
    Ibrahim, A
    Naccache, P
    Ulusakarya, A
    Pico, JL
    Hayat, M
    BLOOD, 1996, 88 (10) : 3852 - 3852
  • [30] High-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's lymphoma: a single center experience
    Sperotto, A
    Zaja, F
    Damiani, D
    Patriarca, F
    Geromin, A
    Fanin, R
    HAEMATOLOGICA, 2001, 86 (12) : 1317 - 1318
12345